Interferon‐α‐2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease‐2019

AIMS: Type 1 interferon (IFN) is used to treat patients with coronavirus disease‐2019 (COVID‐19) but robust supporting evidence is lacking. We investigated the association between IFN‐α‐2b and the clinical outcomes of patients with COVID‐19. METHODS: A total of 1401 patients were enrolled, with 852...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Clin Pharmacol
Главные авторы: Yu, Jiong, Lu, Xuan, Tong, Ling, Shi, Xiaowei, Ma, Jing, Lv, Feifei, Wu, Jian, Pan, Qiaoling, Yang, Jinfeng, Cao, Hongcui, Li, Lanjuan
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2021
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239515/
https://ncbi.nlm.nih.gov/pubmed/33982806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14898
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы